On March 12, 2017, Baiyu’s key product Ginkgolide injection was awarded “Innovative Drugs with Most Clinical Value(Herbal Medicinal Products)” in the Second Selection Activity of Most Innovative Brand in Chinese Pharmaceutical Industry. Ginkgolide injection is the only herbal products which received the honor.

The activity is organized by Chinese Academy of Medical Sciences, China Academy of Chinese Medical Sciences and China Pharmaceutical Innovation and Research Development Association and government officers from The National People’s Congress of the People’s Republic of China, Chinese Food and Drug Administration, etc attended the award ceremony.

The award inspires Baiyu to continue drug innovation and set a higher level for Ginkgolide injection which means we need to dig out more indications for Ginkgolide injection.